Navigation Links
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
Date:2/26/2013

rom RMB280.7 million in the prior year period.
  • New subscriber sign-ups reached 56,169 and the accumulated subscriber base expanded to 295,923.
  • Gross profit increased by 44.2% to RMB313.4 million ($50.3 million) from RMB217.4 million in the prior year period.
  • Operating income increased by 58.6% to RMB158.6 million ($25.5 million) from RMB100.0 million in the prior year period.
  • Interest expense amounted to RMB48.0 million ($7.7 million), compared to RMB2.4 million in the prior year period.
  • Income before income tax was RMB124.6 million ($20.0 million), up 9.9%.
  • In the absence of the one-time tax benefit, net income attributable to the Company amounted to RMB89.4 million ($14.4 million), compared to RMB102.7 million in the prior year period.
  • Operating cash inflow for the first nine months of fiscal 2013 was RMB423.6 million ($68.0 million).
  • "The Company reached a major milestone in the third quarter of fiscal 2013 as we, for the first time, exceeded the 20,000 mark in quarterly new subscriber numbers, representing the highest increase in our new subscriber sign-ups in any single quarter, and generated record quarterly revenues," stated Ms. Ting Zheng, Chief Executive Officer of CCBC.  "Such achievements reflect our management team's years of dedication to setting out clear strategies and marketing approaches to optimize our marketing campaign, payment methods, and client base.  Our robust financial performance reflects the harvest of our continuous efforts to deepen penetration in our existing markets, which leads to ongoing expansion in our subscriber base, as well as increasingly high earnings and cash flows.  By continuously revamping our marketing approach, we have been able to achieve our short-to-medium term objectives in today's dynamic business environment."

     Summary – The Third Quarter and First Nine Months Ended December 31, 2011 and 2012Three Months
    '/>"/>

    SOURCE China Cord Blood Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related biology technology :

    1. China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results
    2. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
    3. Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    4. Lucintel’s Analysis of Growth Opportunities in China’s Composites Industry: Expect Market to Surpass $11 Billion in 2017
    5. China Cord Blood Corporation to Further Consolidate its Corporate Structure
    6. Biomaterials China News 1210 - Annual Subscription
    7. China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013
    8. China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
    9. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2013 Financial Results
    10. China Biologic Products to Report Third Quarter 2012 Financial Results
    11. Life Technologies New State-of-the-Art Manufacturing Facility in China Provides Forensics Labs Rapid Access to World-Leading DNA Testing Solutions
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... Colo. , Jan. 23, 2015  Array BioPharma Inc. ... has reached a definitive agreement with Novartis Pharma AG ... inhibitor currently in Phase 3 development.  This agreement is conditional ... GlaxoSmithKline PLC (GSK) on April 22, 2014, which are expected ...
    (Date:1/22/2015)... Davis, California (PRWEB) January 22, 2015 ... of Accelerator Mass Spectrometry (AMS) services to the pharmaceutical ... PhD has joined the company in the position of ... 30 years of broad and valuable experience in drug ...
    (Date:1/22/2015)... RBJ today announces the firm brokered a long-term lease totaling ... biopharmaceutical company, at Two Ledgemont Center in Lexington, ... president, and Brian Cohen , senior vice president, represented ... 95 Hayden Ave. Photo - http://photos.prnewswire.com/prnh/20150122/170765 ...
    (Date:1/22/2015)... 22, 2015  Transwestern | RBJ today announces the firm brokered ... for Shire a leading biopharmaceutical company, at Two Ledgemont Center ... Robert Richards , president, and Brian Cohen , ... entire five-floor building at 95 Hayden Ave. Photo ...
    Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 2Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 3Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2
    ... Calif., June 18 California,s,plans to join in cooperative ... of Victoria should be supported so long as they ... glitz of playing on the,world stage, said Consumer Watchdog., ... Taxpayer,and Consumer Rights, noted that the state,s stem cell ...
    ... DIEGO, June 18 PacificGMP and Pacific ... a definitive merger agreement,and will develop a ... organization (CMO) in Taizhou, China. At,approximately 200,000 ... Biomedicine (CQB), will be one of the ...
    ... 18 Inverness Medical,Innovations, Inc. (Amex: IMA ... products for the consumer and professional markets, today,announced ... Russell, Vice,President, Finance, will attend the Jefferies 2nd ... York. Inverness, presentation is,scheduled for Wednesday, June 25 ...
    Cached Biology Technology:California's International Stem Cell Collaborations Must Be Based on Scientific Merit, Consumer Group Says 2PacificGMP to Merge With Pacific Biopharma Group and Create Innovative US-Compliant cGMP Contract Biomanufacturing Facility in China 2Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008 2
    (Date:12/17/2014)... DENVER , Dec. 16, 2014  Automation is fundamentally ... evident than at international borders. Over the past decade, ... veteran travelers to self process through border control via ... increasing number of airports, seaports, and land borders across ...
    (Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ...
    (Date:12/10/2014)... 2014  Wake Forest Baptist Medical Center today announced plans for ... Funding for this $50 million capital project is part of ... summer. The medical education building will be ... complex, adjacent to 525@vine in Wake Forest Innovation Quarter. Construction ...
    Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
    ... a developer of,cyber intelligence tools for information security, ... headed by the appointment of,Donnie Blanks as chief ... of Sales and strategy for Perot,Systems, government business ... continues to advance its industry presence and paradigm-shifting,security ...
    ... Harvard researchers reported that children with autism have a ... to develop a simple genetic test to identify the ... imaging to reveal correlations in the facial features and ... which will enable them to develop a formula for ...
    ... knew what possessed the young Jim Sacchettini to become a ... But that story,s for later. Instead, ponder what Sacchettini calls ... long ago were considered wiped from the face of the ... these maladies firsthand in the Bronx. He had gone there ...
    Cached Biology News:NeuralIQ Expands Global Leadership Team, Names Donnie Blanks CEO 2NeuralIQ Expands Global Leadership Team, Names Donnie Blanks CEO 3Researchers study facial structures, brain abnormalities to reveal formula for detection of autism 2College cocktails lead to science career 2
    IC50: 3 ng/ml · Limit of detection: 0.9 ng/ml...
    Request Info...
    Request Info...
    ... Ambion's custom siRNA service provides the premium ... silencing research. Custom siRNAs can be readily ... base target sequence, or by providing the ... out Ambion's Silencer Validated and Silencer Pre-designed ...
    Biology Products: